RAB4A and neoplasm: Specifically, we compared the tumor formation ability of cells derived from MDA‐MB‐231 that expressing either control shRNA or RAB4A shRNA alone or concurrent expression of RAB4A shRNA and either RAC1WT or RAC1CA.